BRAT1 encephalopathy: a recessive cause of epilepsy of infancy with migrating focal seizures
Ingrid E Scheffer, Katja E Boysen, Amy L Schneider, Candace T Myers, Michele G Mehaffey, Anne M Rochtus, Yuet-Ping Yuen, Gabriel Ronen, Wai Km Chak, Deepak Gill, Annapurna Poduri, Heather C Mefford
Developmental Medicine & Child Neurology | WILEY | Published : 2019
The authors thank the patients and their families for participating in our research program and thank Fiona Gardiner for her assistance with manuscript preparation. IES serves on the editorial boards of Neurology and Epileptic Disorders; may accrue future revenue on a pending patent WO61/010176: Therapeutic Compound that relates to discovery of PCDH19 gene as the cause of familial epilepsy with mental retardation limited to females; is one of the inventors listed on a patent held by Bionomics Inc. on diagnostic testing of using the SCN1A gene, WO2006/133508; has received speaker honoraria from UCB, GSK, BioMarin, Xenon Pharma, and Nutricia; has received funding for travel from UCB, GSK, and BioMarin; and receives/has received research support from the National Health and Medical Research Council of Australia, Health Research Council of New Zealand, CURE, March of Dimes, and NIH/NINDS. AP receives research support from the NIH/NINDS. HCM receives research support from the NIH/NINDS. All other authors report no disclosures.